• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主要肠道微生物群的特定成员可预测 UC 患者结肠切除和回肠贮袋肛管吻合术后 pouchitis 的发生。

Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC.

机构信息

Translational Research Center for Gastrointestinal Disorders (TARGID), University Hospital Leuven, KU Leuven, Leuven, Belgium.

Department Microbiology and Immunology, KU Leuven, Leuven, Belgium.

出版信息

Gut. 2017 Jan;66(1):79-88. doi: 10.1136/gutjnl-2015-309398. Epub 2015 Sep 30.

DOI:10.1136/gutjnl-2015-309398
PMID:26423113
Abstract

OBJECTIVE

Pouchitis is the most common complication after colectomy with ileal pouch-anal anastomosis (IPAA) for UC and the risk is the highest within the 1st year after surgery. The pathogenesis is not completely understood but clinical response to antibiotics suggests a role for gut microbiota. We hypothesised that the risk for pouchitis can be predicted based on the faecal microbial composition before colectomy.

DESIGN

Faecal samples from 21 patients with UC undergoing IPAA were prospectively collected before colectomy and at predefined clinical visits at 1 month, 3 months, 6 months and 12 months after IPAA. The predominant microbiota was analysed using community profiling with denaturing gradient gel electrophoresis followed by quantitative real-time PCR validation.

RESULTS

Cluster analysis before colectomy distinguished patients with pouchitis from those with normal pouch during the 1st year of follow-up. In patients developing pouchitis, an increase of Ruminococcus gnavus (p<0.001), Bacteroides vulgatus (p=0.043), Clostridium perfringens (p=0.011) and a reduction of two Lachnospiraceae genera (Blautia (p=0.04), Roseburia (p=0.008)) was observed. A score combining these five bacterial risk factors was calculated and presence of at least two risk factors showed a sensitivity and specificity of 100% and 63.6%, respectively.

CONCLUSIONS

Presence of R. gnavus, B. vulgatus and C. perfringens and absence of Blautia and Roseburia in faecal samples of patients with UC before surgery is associated with a higher risk of pouchitis after IPAA. Our findings suggest new predictive and therapeutic strategies in patients undergoing colectomy with IPAA.

摘要

目的

pouchitis 是 UC 患者接受结肠切除和回肠储袋肛管吻合术(IPAA)后最常见的并发症,其风险在手术后的 1 年内最高。发病机制尚不完全清楚,但抗生素的临床疗效提示肠道微生物群起作用。我们假设 pouchitis 的风险可以基于手术前粪便微生物组成来预测。

设计

前瞻性收集 21 例 UC 患者行 IPAA 术前粪便样本,并在 IPAA 后 1 个月、3 个月、6 个月和 12 个月时进行预定的临床随访。采用变性梯度凝胶电泳进行群落分析,随后用定量实时 PCR 进行验证,分析主要微生物群。

结果

术前聚类分析可区分 1 年内发生 pouchitis 和无 pouchitis 的患者。在发生 pouchitis 的患者中,观察到 Ruminococcus gnavus(p<0.001)、Bacteroides vulgatus(p=0.043)、Clostridium perfringens(p=0.011)增加,以及两个 Lachnospiraceae 属(Blautia(p=0.04)、Roseburia(p=0.008)减少。计算了这些 5 种细菌风险因素的综合评分,存在至少 2 种风险因素的敏感性和特异性分别为 100%和 63.6%。

结论

UC 患者术前粪便样本中存在 R. gnavus、B. vulgatus 和 C. perfringens,以及缺乏 Blautia 和 Roseburia 与 IPAA 后 pouchitis 的风险增加相关。我们的发现为接受结肠切除和 IPAA 的患者提供了新的预测和治疗策略。

相似文献

1
Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC.主要肠道微生物群的特定成员可预测 UC 患者结肠切除和回肠贮袋肛管吻合术后 pouchitis 的发生。
Gut. 2017 Jan;66(1):79-88. doi: 10.1136/gutjnl-2015-309398. Epub 2015 Sep 30.
2
Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa.袋状结构炎症与特定细菌分类群丰度的降低有关。
Gastroenterology. 2015 Sep;149(3):718-27. doi: 10.1053/j.gastro.2015.05.041. Epub 2015 May 27.
3
Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis.溃疡性结肠炎行结直肠切除术后储袋微生物群与储袋炎之间的关系。
World J Gastroenterol. 2014 Aug 7;20(29):9665-74. doi: 10.3748/wjg.v20.i29.9665.
4
Microbiome Analysis of Mucosal Ileoanal Pouch in Ulcerative Colitis Patients Revealed Impairment of the Pouches Immunometabolites.溃疡性结肠炎患者黏膜回肠贮袋微生物组分析显示贮袋免疫代谢物受损。
Cells. 2021 Nov 19;10(11):3243. doi: 10.3390/cells10113243.
5
Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis.溃疡性结肠炎和家族性腺瘤性息肉病患者的袋炎与健康袋之间存在明显不同的微生物组。
Inflamm Bowel Dis. 2011 May;17(5):1092-100. doi: 10.1002/ibd.21460. Epub 2010 Sep 15.
6
Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.针对糖蛋白 2 的抗体是回肠贮袋患者肠道炎症的新型标志物。
J Crohns Colitis. 2013 Dec;7(11):e522-32. doi: 10.1016/j.crohns.2013.03.009. Epub 2013 Apr 30.
7
Fecal microbiota in pouchitis and ulcerative colitis.储袋炎和溃疡性结肠炎中的粪便微生物群。
World J Gastroenterol. 2016 Oct 28;22(40):8929-8939. doi: 10.3748/wjg.v22.i40.8929.
8
Survival of ileal pouch anal anastomosis constructed after colectomy or secondary to a previous ileorectal anastomosis in ulcerative colitis patients: a population-based cohort study.溃疡性结肠炎患者结肠切除术后或继发于先前回直肠吻合术后行回肠储袋肛管吻合术的生存率:一项基于人群的队列研究。
Scand J Gastroenterol. 2017 May;52(5):531-535. doi: 10.1080/00365521.2016.1278457. Epub 2017 Jan 19.
9
Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis.益生菌对溃疡性结肠炎患者行J形回肠贮袋肛管吻合术重建术后症状及内镜表现进行四周干预的结果
Scand J Gastroenterol. 2005 Jan;40(1):43-51. doi: 10.1080/00365520410009339.
10
Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA).对接受J形回肠储袋肛管吻合术(IPAA)的患者进行四周益生菌干预后,评估其黏膜炎症和血流情况。
Scand J Gastroenterol. 2004 Dec;39(12):1228-35. doi: 10.1080/00365520410009320.

引用本文的文献

1
Optimal Approaches to Treating and Preventing Acute and Chronic Pouchitis by Altering Microbial Profiles.通过改变微生物谱治疗和预防急慢性袋炎的最佳方法。
Gastroenterol Clin North Am. 2025 Jun;54(2):469-483. doi: 10.1016/j.gtc.2024.12.007. Epub 2025 Jan 9.
2
Navigating Chronic Pouchitis: Pathogenesis, Diagnosis, and Management.慢性袋炎的诊治:发病机制、诊断与管理
Gastroenterol Hepatol (N Y). 2025 Jan;21(1):46-58.
3
Gut Microbiome and Metabolome Changes in Chronic Low Back Pain Patients With Vertebral Bone Marrow Lesions.
伴有椎体骨髓损伤的慢性下腰痛患者的肠道微生物组和代谢组变化
JOR Spine. 2025 Jan 27;8(1):e70042. doi: 10.1002/jsp2.70042. eCollection 2025 Mar.
4
Diet and Microbiota Modulation for Chronic Pouchitis: Evidence, Challenges, and Opportunities.饮食与微生物群调节对慢性袋炎的作用:证据、挑战与机遇
Nutrients. 2024 Dec 16;16(24):4337. doi: 10.3390/nu16244337.
5
Development of engineered IL-36γ-hypersecreting Lactococcus lactis to improve the intestinal environment.工程化 IL-36γ 高分泌乳球菌的开发,以改善肠道环境。
World J Microbiol Biotechnol. 2024 Oct 24;40(11):363. doi: 10.1007/s11274-024-04157-x.
6
Fecal microbiota and metabolites in the pathogenesis and precision medicine for inflammatory bowel disease.粪便微生物群及其代谢产物在炎症性肠病发病机制与精准医学中的作用
Precis Clin Med. 2024 Sep 23;7(3):pbae023. doi: 10.1093/pcmedi/pbae023. eCollection 2024 Sep.
7
Acupuncture influences multiple diseases by regulating gut microbiota.针刺通过调节肠道菌群影响多种疾病。
Front Cell Infect Microbiol. 2024 Jul 8;14:1371543. doi: 10.3389/fcimb.2024.1371543. eCollection 2024.
8
Ileal Paneth Cell Phenotype is a Cellular Biomarker for Pouch Complications in Ulcerative Colitis.回肠潘氏细胞表型是溃疡性结肠炎储袋并发症的一种细胞生物标志物。
J Crohns Colitis. 2024 Jul 2;18(12):2010-22. doi: 10.1093/ecco-jcc/jjae105.
9
Gut microbiome in the Graves' disease: Comparison before and after anti-thyroid drug treatment.肠道微生物组在格雷夫斯病中的作用:抗甲状腺药物治疗前后的比较。
PLoS One. 2024 May 31;19(5):e0300678. doi: 10.1371/journal.pone.0300678. eCollection 2024.
10
The aetiology of pouchitis in patients with inflammatory bowel disease.炎症性肠病患者袋炎的病因
Therap Adv Gastroenterol. 2024 May 27;17:17562848241249449. doi: 10.1177/17562848241249449. eCollection 2024.